SEC Form 4 · accession 0001140361-16-054824
IDEXX LABORATORIES INC /DE · IDXX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
M Anne Szostak
Director
Period of report
Feb 17, 2016
Accepted (ET)
Feb 25, 2016 · 2:27 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000874716
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 17, 2016 | P | 2,000 | $69.9405 | A | 8,816 | I | M. Anne Szostak Trust |
| Common Stock | holding | — | — | — | 584 | D | ||
| Common Stock | holding | — | — | — | 6,600 | I | 2014 Szostak IDEXX GRAT |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The purchase price reported reflects the weighted average purchase price of multiple transactions on the reported date at prices that ranged from $69.890 to $69.980, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price within the range.